Reports for TAKEDA CANADA INC

Company Name

TAKEDA CANADA INC

Totals

Shortage reports

52
Actual shortage: 1 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 51 (98%)

Discontinuation Reports

7
To be discontinued: 0 (0%)
Discontinued: 7 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VYVANSE 40MG CAPSULE Resolved 2021-09-22 2021-10-07 146031
VYVANSE 40MG CAPSULE Resolved 2021-12-02 2021-12-12 150414
VYVANSE 60MG CAPSULE Resolved 2021-12-02 2021-12-12 150420
VYVANSE 10MG CAPSULE Resolved 2017-04-06 2017-04-13 5797
VYVANSE 10MG CAPSULE Resolved 2018-07-06 2018-07-14 54721
VYVANSE 10MG CAPSULE Resolved 2021-09-22 2021-10-07 146027
VYVANSE 10MG CAPSULE Resolved 2022-06-03 2022-07-08 161811
VYVANSE 10MG CAPSULE Resolved 2023-08-30 2023-09-14 203355
VYVANSE 10MG CAPSULE Resolved 2024-02-27 2024-03-18 220802
VYVANSE 70MG CAPSULE Resolved 2018-06-04 2018-06-13 51253
VYVANSE 10MG TABLET (CHEWABLE) Resolved 2021-12-02 2021-12-12 150423
VYVANSE 40MG TABLET (CHEWABLE) Resolved 2023-02-24 2023-03-07 185609

Showing 41 to 52 of 52

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACTOS 15MG TABLET Discontinued 2018-04-02 2018-04-02 44428
ACTOS 30MG TABLET Discontinued 2018-04-02 2018-04-02 44433
ACTOS 45MG TABLET Discontinued 2018-04-02 2018-04-02 44438
AGRYLIN 0.5MG CAPSULE Discontinued 2023-11-15 2024-03-01 210182
FOSRENOL 250MG TABLET (CHEWABLE) Discontinued 2022-12-20 2023-04-30 178916
PANTO IV 40MG POWDER FOR SOLUTION Discontinued 2017-03-15 2017-03-15 2969
ULORIC 80MG TABLET Discontinued 2021-08-17 2022-01-04 144266

Showing 1 to 7 of 7